Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Ziextenzo (pegfilgrastim)
pCPA File Number:
21203
Negotiation Status:
Concluded with an LOI
Indication(s):
febrile neutropenia in non-myeloid malignancies
Sponsor/Manufacturer:
Sandoz Canada
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
2020-04-27
Negotiation Process Concluded:
2020-07-22